designated "macro-CK type 2," which also migrates cathodal to CK-MM (10-12).
Isoenzymes of creatine kinase (CK; EC 2.7.3.2) are routinely identified by electrophoresis in agarose, followed by fluorometry.
The presence of CK-MB, combined with a serial increase in lactate dehydrogenase (EC 1.1.1.27) isoenzyme 1 in serum, has a sensitivity and specificity for acute myocardial infarction approaching 100% (1) (2) (3) (4) . However, accurate assessment of CK-MB by electrophoresis is occasionally thwarted by the presence of unusual bands, which may make identification and quantification of CK-MB difficult.
Several unusual CK isoenzymes and isoenzyme complexes have been reported after electrophoresis designated "macro-CK type 2," which also migrates cathodal to CK-MM (10-12).
We present here a systematic approach in which commercially available reagents can be used to identify macro-CK type 1 and other CK variants, including those that migrate electrophoretically as CK-MB.
Materials and Methods
We determined total CK activity with a Cobas-Bio centrifugal analyzer (Roche Analytical Instruments, Nutley, NJ
07110) and Spinchem
CK-NAC reagent (SmithKline Instruments, Sunnyvale, CA 94086). CK isoenzymes electrophoretically separated on agarose were quantified fluorometncally (Corning Medical, Medfleld, MA 02052). These procedures were performed according to the manufacturer's protocols.
We also determined CK-MB activity by an immunochemical method (Isomune-CK, Roche Diagnostics), according to the manufacturer's procedure; we measured its activity by the same method as for total serum CK. We determined the mass of CK-MB immunoenzymetrically (Tandem"-E CKMB; Hybritech Inc., San Diego, CA 92121).
To characterize observed CK bands, one can use the procedures outlined in Figure 1 as follows: 1. To rule out the presence of non-CK fluorescence on the electrophoretic plate, use a substrate lacking phosphocreatine (CK-US isoenzyme blank reagent; Helena Laboratories, Beaumont, TX 77704).
2. To determine whether IgG-macro-CK type 1 complex is present, treat the sera with immobilized Protein A (13). In brief, add 1 mL of serum to 100 mg of Protein A-Sepharose CL-4B (Pharmacia Fine Chemicals, Piscataway, NJ 08854), mix this suspension for 15 mm, then centrifuge at 1000 x g for 5 mm. Electrophorese the supernate on agarose as above. Absence of the initial suspect band identifies it as IgGmacro-CK type 1.
3. To remove the presumptive native CK-BB-specific immunoglobulin from the Protein A-Sepharose CL-4B, wash the Sepharose with 10 mL of glycine HC1 buffer (50 mmolJL, pH 3.0 at 25#{176}C) (10), mix this suspension for 15 miii, then centrifuge at 1000 x g for 5 mm. Remove the supernate, adjust its pH to 7.0 with 0.1 molfL sodium hydroxide and concentrate it to 500 pL (we used an a Model B15 concentrator ifiter; Amicon Corp., Danvers, MA 01923).
To determine the CK-BB binding ability of the immunoglobulin just isolated, incubate 50 tL of the concentrated solution for 10 mm with 10 pL of human vitreous humor (which contains only CK-BB activity), and electrophorese the mixture on agarose. Figure 2B) . Aliquots of the patient's serum were assayed by Isomune-CK and Tandem-E CKMB, and no CK-MB activity or mass was detected. However, all electrophoretic bands were shown to represent true CK activity, and the apparent CK-MB band represented 12 U/L of activity.
The agarose electrophoretic pattern observed after treatment of the patient's serum with Proteun-A-Sepharose CL-4B is shown in Figure 2C . Removal of the band between CK-MM and CK-MB confirmed its identify as a macro-CK type 1 containing a IgG-CK complex. Electrophoresis of this supernate after immunoprecipitation of M-subunit-containmg isoenzymes revealed the pattern shown in Figure 21 ). CK-MM was removed but the isoenzyme migrating as CK-MB was not, indicating that this band represented an isoenzyme lacking typical M subunits. Treatment of control sera containing typical CK-MB demonstrated that the procedure was capable of removing this isoenzyme when present.
As can be seen in Figure 2C , the band migrating as CK-MB was unaffected by Protein-A-Sepharose and therefore was not an IgG'-macro-CK type 1. After removal of the IgG.-macro-CK type 1, the patient's serum was incubated with an anti-IgA precipitating antibody and electrophoresed. The CK-MB migrating isoenzyme was still present with unaltered mobility, indicating that the variant isoenzyme was not a macro-CK type 1 containing IgA.
After separation from Protein A-Sepharose CL-4B, the immunoglobulin isolated from the macro-CK type 1 present in the patient's serum was capable of binding CK-BB from other sources, as demonstrated by the formation of a new macro-CK type 1 band migrating between CK-MM and CK-MB (Figure 2, E and F) . This immunoglobulin exhibited no binding activity towards this patient's isoenzyme migrating as CK-MB or towards typical CK-MB in control sera. However, monoclonal antibody to CK-B subunit exhibited binding activity towards both the variant isoenzyme, CK-BB, and CK-MB, as manifested by alteration of electrophoretic mobility (14) (Figure 2G) . Using our approach, we identified an IgG-macro-CK type 1 and a CK variant migrating as CK-MB in the same serum We believe that the protocol outlined in this report provides a systematic approach to categorizing abnormal, variant CK isoenzymes.
The presence of non-CK fluorescence, macro-CK complexes, and the antigemcity of electrophoretic bands can be ascertained. Further, this protocol can be applied to the investigation of discrepant CK-MB results for sera examined by both electrophoresis and immunological methods.
